These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 21109835)
1. [Severe factual errors in Tidsskriftet]. Eikeland T Tidsskr Nor Laegeforen; 2010 Nov; 130(22):2219. PubMed ID: 21109835 [No Abstract] [Full Text] [Related]
2. [A reply concerning scientologists and ADHD: Scientific evidence and indications for treatment with methylphenidate]. Zetterström R Lakartidningen; 2002 Mar; 99(14):1618-9. PubMed ID: 12025221 [No Abstract] [Full Text] [Related]
3. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny. Strawn MN J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255 [No Abstract] [Full Text] [Related]
4. New Ritalin ad blitz makes parents jumpy. Novak V Time; 2001 Sep; 158(10):62-3. PubMed ID: 11558351 [No Abstract] [Full Text] [Related]
7. Evidence and belief in attention deficit hyperactivity disorder. Reintroduction of methylphenidate in Italy needs careful monitoring. Bonati M; Impicciatore P; Pandolfini C BMJ; 2001 Mar; 322(7285):556. PubMed ID: 11263458 [No Abstract] [Full Text] [Related]
8. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Pae CU Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730 [No Abstract] [Full Text] [Related]
9. Methylphenidate. St Dennis C; Synoground G J Sch Nurs; 1996 Feb; 12(1):5-8, 10-1. PubMed ID: 8696016 [No Abstract] [Full Text] [Related]
10. [Methylphenidate. A drug for attention deficit disorders to be used with precaution]. Taéron C Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855 [No Abstract] [Full Text] [Related]
11. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment]. Oberpichler-Schwenk H Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689 [No Abstract] [Full Text] [Related]
12. Pushing pills on kids? Lawyers claim a conspiracy to oversell Ritalin. Shute N US News World Rep; 2000 Oct; 129(13):60. PubMed ID: 11183332 [No Abstract] [Full Text] [Related]
15. Visual fields in children with attention-deficit/hyperactivity disorder before and after treatment with stimulants. Ghanizadeh A Acta Ophthalmol; 2010 Mar; 88(2):e56. PubMed ID: 19508459 [No Abstract] [Full Text] [Related]
16. Transdermal methylphenidate (Daytrana) for ADHD. Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850 [No Abstract] [Full Text] [Related]
17. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder. Olfson M; Marcus SC; Zhang HF; Wan GJ J Clin Psychopharmacol; 2008 Apr; 28(2):255-7. PubMed ID: 18344749 [No Abstract] [Full Text] [Related]
18. Clonidine for treatment of attention-deficit/hyperactivity disorder. Med Lett Drugs Ther; 1996 Dec; 38(989):109-10. PubMed ID: 8957471 [No Abstract] [Full Text] [Related]
19. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment]. 't Jong GW; van den Anker JN Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263 [No Abstract] [Full Text] [Related]
20. [Central stimulants in the treatment of children with ADHD: unknown long-term effect and uncertain pharmacological documentation]. Zetterström R Lakartidningen; 2002 Feb; 99(7):677-80. PubMed ID: 11887717 [No Abstract] [Full Text] [Related] [Next] [New Search]